The Role of Point-of-care Polymerase Chain Reaction in Managing Nosocomial Pneumonia
NCT ID: NCT05928208
Last Updated: 2023-07-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2017-02-01
2023-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Validity of Biological Material Sampling in Patients With Hospital-acquired Pneumonia
NCT03039998
Azithromycin as a Quorum-Sensing Inhibitor for the Prevention of Pseudomonas Aeruginosa Ventilator-Associated Pneumonia
NCT00610623
Pathogen Identification of Bacterial Pneumonia Via DNA Detection
NCT00567827
Community-Acquired Pneumonia Diagnosis Through Integrating Novel Microbiological Techniques.
NCT06259110
Performance of New Diagnostic Methods in Older Adults With Pneumonia
NCT06092008
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no intervention
no intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* radiological findings typical for pneumonia
* signs of infection
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Iuliu Hatieganu University of Medicine and Pharmacy
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Balan Andrei Mihai
MD, Phd student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrei Balan, MD
Role: PRINCIPAL_INVESTIGATOR
Universitatea de Medicina si Farmacie "Iuliu Hatieganu" Cluj-Napoca
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Spitalul Clinic Judetean de Urgenta Cluj
Cluj-Napoca, Cluj, Romania
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
82/03.03.2017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.